300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Mobile
Digital Media
Big Data
Email
Artificial Intelligence
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
Clean Energy
InsurTech
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Celebrity
Infrastructure
Social
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Cannabis
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
LGBT
Climate
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Egypt
United Kingdom
Oceania
Argentina
Singapore
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
Oman
LATAM
Puerto Rico
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
France
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
United States
Tanzania
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Bangladesh
Barbados
Belgium
Angola
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Ecuador
Bulgaria
Qatar
Bahamas
Bahrain
Bolivia
Estonia
Jersey
Belize
Algeria
Belarus
Hungary
Grenada
Israel
Honduras
Lithuania
Iceland
Cambodia
Finland
Liechtenstein
Lebanon
Mongolia
Italy
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Angel Investors (November 2026)

The most active angel investors investing in Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
37 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $505k–$56M
Milad Alucozai
Angel
26 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $113k–$60M
Christopher Gibson
Angel
18 United States, United Kingdom, France Series A, Seed, Series B Biotechnology, Health Care, Pharmaceutical $1.5M–$55M
Jeffrey Dean
Angel
16 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Artificial Intelligence, Software, Information Technology $450k–$60M
Sahin Boydas
Angel
16 United States, Canada, Mexico Seed, Series A, Series B Artificial Intelligence, Software, Information Technology $500k–$150M
Charlie Songhurst
Angel
14 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$24M
Jude Gomila
Angel
13 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $70k–$4.7M
Paul Buchheit
Angel
12 United States, Canada, India Seed, Series A, Angel Software, SaaS, Health Care $100k–$14M
Sam Altman
Angel
12 United States, Canada, Ghana Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.2M–$100M
Edward Lando
Angel
12 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, FinTech, Artificial Intelligence $125k–$31M
Balaji Srinivasan
Angel
11 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $650k–$28M
Jaffray Woodriff
Angel
10 United States Seed, Series A, Angel Software, Biotechnology, Health Care $250k–$11M
Farzad Nazem
Angel
10 United States, Canada Seed, Series A, Series B Health Care, Software, Analytics $750k–$50M
Alice Zhang
Angel
9 United States, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Therapeutics $120k–$30M
Kingsley Advani
Angel
9 United States, Singapore, United Kingdom Seed, Pre-Seed, Series A FinTech, Financial Services, Biotechnology $120k–$183M
Jeff Hammerbacher
Angel
9 United States, Germany Seed, Series A, Angel Artificial Intelligence, Software, Biotechnology $330k–$25M
bumpkins profile
Angel
9 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Medical $500k–$57M
Ling Wong
Angel
9 United States, Colombia Seed, Series A, Series C Health Care, Biotechnology, Medical $4.4M–$450M
Wei Guo
Angel
8 United States, China, Canada Seed, Series A, Angel Software, Artificial Intelligence, Internet $120k–$19M
James Mellon
Angel
8 United States, United Kingdom, Israel Series A, Seed Biotechnology, Food and Beverage, Food Processing $894k–$47M
Dimitri Seas
Angel
8 United States, Hong Kong, United Kingdom Seed, Pre-Seed, Series A Robotics, Health Care, Artificial Intelligence $231k–$4.2M
Rand Hindi
Angel
7 France, United States, Germany Seed, Pre-Seed Cryptocurrency, Software, Machine Learning $125k–$11M
Marc Benioff
Angel
7 United States, United Kingdom, Canada Series A, Seed, Series B Software, Health Care, Artificial Intelligence $935k–$50M
Erik Peterson
Angel
7 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, SaaS, Mobile $69k–$20M
Nadav Rosenberg
Angel
7 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $1.1M–$21M
Esther Dyson
Angel
7 United States, Egypt, Canada Seed, Series A, Angel Health Care, Software, Artificial Intelligence $330k–$16M
John Ballantyne
Angel
7 United States, Singapore Seed, Series A, Angel Health Care, Biotechnology, Therapeutics $4.5M–$30M
Chris Gibson
Angel
7 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
Elad Gil
Angel
7 United States, United Kingdom, Israel Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $2M–$117M
Bill Gates
Angel
6 United States, Canada, Israel Series C, Series A, Series B Energy, Biotechnology, Renewable Energy $12M–$161M
Peter Thiel
Angel
6 United States, Germany, Canada Series A, Seed, Series B Software, FinTech, Financial Services $1.2M–$105M
Evan Cheng
Angel
6 United States, United Kingdom, Australia Seed, Pre-Seed, Series A Software, Artificial Intelligence, Biotechnology $120k–$18M
Zach Weinberg
Angel
6 United States, Israel, Colombia Seed, Series A, Pre-Seed Software, Health Care, SaaS $1.5M–$30M
Eric Kwan
Angel
6 United States, India, Canada Seed, Pre-Seed, Series A Software, FinTech, E-Commerce $125k–$21M
Tim Draper
Angel
6 United States, United Kingdom, Canada Seed, Series A, Series B Software, FinTech, Financial Services $350k–$50M
Sake Bosch
Angel
6 The Netherlands, France, Israel Seed, Series A, Series B Software, E-Commerce, Biotechnology $1.3M–$101M
Anne Wojcicki
Angel
6 United States, United Kingdom, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$70M
Bradley Horowitz
Angel
6 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $150k–$36M
Stefano Bernardi
Angel
6 Italy, United Kingdom, Canada Seed, Pre-Seed Blockchain, Software, Biotechnology $100k–$18M
Daniel Curran
Angel
6 United States, Canada, Brazil Seed, Series A, Series B E-Commerce, Software, Internet $250k–$50M
Maxim Basov
Angel
6 Russian Federation, United States Seed, Angel, Pre-Seed Health Care, Apps, Legal $1.1M–$1.5M
Cory Levy
Angel
6 United States, Canada, Peru Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $200k–$72M
Kevin Moore
Angel
6 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $300k–$4M
Nadav Ben-Chanoch
Angel
6 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Artificial Intelligence $120k–$30M
Vishal Rao
Angel
5 United States, India, Canada Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$25M
Bernard Majoie
Angel
5 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care $1.3M–$2.7M
Candan Karabagli
Angel
5 Turkey Seed, Angel, Series A Biotechnology, Analytics, Biopharma $280k–$1.1M
Brian Armstrong
Angel
5 United States, Brazil, Libya Seed, Series A, Series B Biotechnology, Payments, Financial Services $2M–$130M
Fred Ehrsam
Angel
5 United States, Canada, Israel Seed, Series A, Series C Blockchain, Cryptocurrency, Software $1M–$300M
Alec Nielsen
Angel
5 United States, Germany Seed, Pre-Seed Biotechnology, Biopharma, Medical $3M–$16M
Access all 2708 angel investors in Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 37 investments in Biotechnology startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon Discovery Group plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 63
  • Round size: Seed $505k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 26 investments in Biotechnology startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1M–$7M; Pre-Seed $113k–$5M; Series A $13M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Show all investments...

Christopher Gibson
Angel · Salt Lake City, Utah, United States · 18 investments in Biotechnology startups

Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 28
  • Round size: Seed $1.5M–$14M; Series A $10M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zanskar — Zanskar combines field geology, artificial intelligence, and computational geoscience to discover geothermal resources and develop clean, firm power.
  • Play Health — Play Health is no longer available. The team behind it is now building Paceline Bio.
  • Dunia Innovation — Catalysing the energy transition.
Show all investments...

Jeffrey Dean
Angel · Palo Alto, California, United States · 16 investments in Biotechnology startups, 21 in the past 12 months

Jeff Dean is the Co-founder and CEO of DiscoveryLoop. He previously worked at Google as Chief Scientist at Google DeepMind and Google Research. Jeff attended the University of Washington, where he earned a PhD in Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 112
  • Round size: Seed $2.5M–$34M; Pre-Seed $450k–$3M; Series A $10M–$60M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
  • Phinity Labs — Phinity Labs builds AI systems designed to fully automate the entire silicon microchip engineering process, spanning from original architectural concepts to final manufacturing preparation.
  • Volantis — Volantis specializes in developing AI-driven semiconductor solutions. The company focuses on creating advanced systems that support high-performance computing for various applications, including networking, data centers, and edge computing. Volantis provides integrated hardware and software platforms designed to optimize processing power, energyefficiency, and scalability. Their technology aims to enhance the capabilities of existing infrastructure, making it adaptable to emerging computational demands. The company's solutions cater to industries that require robust, efficient computing power at scale.
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 16 investments in Biotechnology startups

Sahin Boydas is the Founder & CEO of Lovie.co. He is part of PEF Community as PEF Chapter Lead.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 291
  • Round size: Seed $500k–$15M; Series A $8M–$36M; Series B $23M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lamb Labs — Lamb Labs is building model processing units that hardcode AI models into silicon for faster, more efficient inference.
  • Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
  • Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 14 investments in Biotechnology startups, 26 in the past 12 months

Charlie Songhurst is a private investor in technology companies. He previously worked at Microsoft as Head of Corporate Strategy. Charlie attended the University of Oxford.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 266
  • Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.1M; Series A $2.9M–$24M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mantic — Mantic is a world-class technical team on a mission to solve the next AI grand challenge: predicting global events with superhuman accuracy, and deploying this capability to power radically improved decision-making in business and government.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
  • Bleu Robotics — Bleu Robotics is an advanced AI and automation company that develops cutting-edge robot learning software designed to deploy humanoid robots seamlessly into industrial environments. Drawing on two decades of academic research in robotics and artificial intelligence, the company addresses the flexibility bottlenecks of traditional, fixed factory automation.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 13 investments in Biotechnology startups

Jude Gomila is based out of San Francisco, California and is the CEO and Founder of Ultrametric. Jude previously worked at Golden as a Founder. Jude Gomila attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$4.7M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Clara — Primary care, supported by AI, that never closes, never rushes you, and never forgets the details.
  • Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 12 investments in Biotechnology startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 167
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — We build products that feel personal, magical and deeply human
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Sam Altman
Angel · San Francisco, California, United States · 12 investments in Biotechnology startups

Sam Altman is the Co-Founder and CEO of OpenAI. Sam previously served as Board Chair at Helion Energy.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Ghana

Investor stats

  • Total investments: 200
  • Round size: Seed $1.2M–$9.3M; Series A $10M–$50M; Series B $17M–$100M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
  • Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
  • Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 12 investments in Biotechnology startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 582
  • Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5M–$31M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 11 investments in Biotechnology startups, 12 in the past 12 months

Balaji Srinivasan is based out of Singapore, Central Region and is the Founder, Investor, and Author of Network School. Balaji previously worked at Coinbase as a CTO. Balaji Srinivasan attended Stanford University.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 276
  • Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Vorflux — 24x7 coworkers that live in Slack. Give AutoBots ongoing responsibilities while you set direction and do the creative work.
  • Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
  • Physical Superintelligence — Physical Superintelligence develops physical superintelligence systems that use AI-driven research to study physics, engineer physical systems, and explore new physical laws. Its approach combines human scientists with virtual physicists that conduct autonomous research campaigns covering hypothesis development, verification, experimentation,engineering, and deployment. The company focuses initially on the physical infrastructure underlying AI, including energy, materials, computation, sensing, and manufacturing.
Show all investments...

Jaffray Woodriff
Angel · Charlottesville, Virginia, United States · 10 investments in Biotechnology startups

Angel Investor located in Charlottesville, VA

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 47
  • Round size: Seed $640k–$4.3M; Angel $250k–$2.6M; Series A $3.4M–$11M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
  • Caju AI — Caju AI revolutionizes customer engagement with Generative AI, boosting your workforce's productivity and providing invaluable business insights. Elevate your customer experience with the power of AI.
  • Starchive — Starchive builds and runs the archives of the greatest brands and artists: IP, catalog, estate and ephemera. Then our creative lab brings them to life.
Show all investments...

Farzad Nazem
Angel · Palo Alto, California, United States · 10 investments in Biotechnology startups

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 130 early stage companies, and sits on the boards of Hand Foundation, and Nautilus Bio. His area of investment is about half in AI, Big Data and Cloud platforms, and half in Health and Biotech. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Show more...

Investment focus

  • Industry: Health Care, Software, Analytics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 65
  • Round size: Seed $750k–$6.5M; Series A $2.8M–$14M; Series B $6M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
  • Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
  • TigerGraph — TigerGraph is the leading graph database for real-time AI and analytics. Detect fraud, resolve entities, and uncover hidden connections at enterprise scale.
Show all investments...

Alice Zhang
Angel · San Francisco, California, United States · 9 investments in Biotechnology startups

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $120k–$5.9M; Series A $12M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Show all investments...

Kingsley Advani
Angel · San Francisco, California, United States · 9 investments in Biotechnology startups

Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $120k–$8.3M; Pre-Seed $120k–$4.5M; Series A $4M–$183M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Checkstep — Moderate text, image, video and audio in 100+ languages with 98% accuracy. Cut moderation costs 90% and stay DSA and OSA compliant. Book a demo.
  • Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
  • Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
Show all investments...

Jeff Hammerbacher
Angel · New York, New York, United States · 9 investments in Biotechnology startups

Jeff Hammerbacher is based out of New York and is the Chairman and Co-Founder of Ortet. Jeff previously worked at New Mountain Capital as a Senior Advisor and Portfolio Company Board Member. Jeff Hammerbacher attended Harvard University.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: United States, Germany

Investor stats

  • Total investments: 36
  • Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lamin — Improve your workflows with open-source data access and long-term memory. Query, trace, and govern with a lineage-native, format-agnostic lakehouse for agents and teams. With support for biological formats and registries.
  • Ridge AI — Ridge builds interactive dashboards and AI data agents you can embed in your product, so customers see the value you deliver. Start a free trial.
  • United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Show all investments...

bumpkins profile
Angel · 9 investments in Biotechnology startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $6.8M–$57M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Show all investments...

Ling Wong
Angel · Seattle, Washington, United States · 9 investments in Biotechnology startups

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for the betterment of humanity today, and in the future. Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong. Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries. As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC). Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series C
  • Geography: United States, Colombia

Investor stats

  • Total investments: 45
  • Round size: Seed $4.4M–$19M; Series A $8.1M–$36M; Series C $50M–$450M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
  • Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
Show all investments...

Wei Guo
Angel · San Francisco, California, United States · 8 investments in Biotechnology startups

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr, Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 196
  • Round size: Seed $120k–$4.3M; Angel $375k–$10M; Series A $3.8M–$19M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
  • Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
  • Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.
Show all investments...

James Mellon
Angel · San José, Islas Baleares, Spain · 8 investments in Biotechnology startups

James Mellon is based out of San José, Islas Baleares, and is the co-founder and chairman of Juvenescence. James previously worked at Griffin Thornton as a trainee fund manager. James Mellon attended the University of Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 35
  • Round size: Seed $894k–$20M; Series A $3M–$47M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Callers AI — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share is a new Caribbean “quirky” golden rum from the islands of Barbados and Jamaica.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Dimitri Seas
Angel · Seattle, Washington, United States · 8 investments in Biotechnology startups

The founder of 2GIS

Show more...

Investment focus

  • Industry: Robotics, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Hong Kong, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $231k–$4.2M; Pre-Seed $365k–$1.7M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Splatica — We turn a 3–5 minute 360° walk-through into a robotic simulation-ready digital twin — fully reconstructed, labeled, and exportable to Isaac Sim in under 24 hours. With 1,500+ scenes built, paying robotics customers, and early revenue, we’re building the infrastructure layer that supplies real-world environments for large-scale robot training.Splatica enables the last mile of sim-to-real — at scale.Finalist of Nebius / Nvidia Physical AI awards.
  • Welltory — Your personal data analyzed and transformed into powerful insights that keep you on track for lifelong health
  • Fluence Cloud — Decentralized and serverless computing, powering the cloudless internet
Show all investments...

Rand Hindi
Angel · Paris, Ile-de-France, France · 7 investments in Biotechnology startups

Rand Hindi is based out of United States and is the General Partner of Unit Ventures. Rand previously worked at Naval Group as an Advisor. Rand Hindi attended Singularity University. Rand Hindi has been awarded Rising Star.

Show more...

Investment focus

  • Industry: Cryptocurrency, Software, Machine Learning
  • Stage:Seed, Pre-Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 40
  • Round size: Seed $2.6M–$11M; Pre-Seed $125k–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
  • Optimum — Optimum constitutes a decentralized, high-performance memory infrastructure tailored for use across various blockchains.
  • Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Show all investments...

Marc Benioff
Angel · San Francisco, California, United States · 7 investments in Biotechnology startups, 7 in the past 12 months

Marc Benioff is based out of San Francisco, California, and is the Chairman, Chief Executive Officer, and Co-Founder of Salesforce. Marc previously worked at Oracle Corporation as a Senior Vice President. Marc Benioff attended the University of Southern California.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 225
  • Round size: Seed $935k–$11M; Series A $5.9M–$30M; Series B $7M–$50M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
  • Wabi — Wabi is the AI assistant you use together. Plan the trip, book the stay, and turn the joke into a game, all in one place.
  • Factory — Factory is bringing autonomy to software engineering.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 7 investments in Biotechnology startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, SaaS, Mobile
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 65
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 7 investments in Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Esther Dyson
Angel · New York, New York, United States · 7 investments in Biotechnology startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Seed, Series A, Angel
  • Geography: United States, Egypt, Canada

Investor stats

  • Total investments: 102
  • Round size: Seed $350k–$3.5M; Angel $330k–$2.9M; Series A $1.5M–$16M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Show all investments...

John Ballantyne
Angel · Fargo, North Dakota, United States · 7 investments in Biotechnology startups

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Angel
  • Geography: United States, Singapore

Investor stats

  • Total investments: 11
  • Round size: Seed $4.5M–$7M; Series A $12M–$30M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • SmartWorx — AI-native platform for regulated, high-stakes environments. Purpose-built to solve the hardest integration and workflow problems where compliance isn't optional.
  • GlucoTrack — We are pleased to announce that the diabetes technology business focused on developing our Continuous Blood Glucose Monitor (CBGM) platform will now operate
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 7 investments in Biotechnology startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 7 investments in Biotechnology startups, 20 in the past 12 months

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 268
  • Round size: Seed $2M–$17M; Series A $9.5M–$55M; Series B $27M–$117M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Lumaril — Lumaril is a software company that develops an artificial intelligence platform for optimizing physical production operations. The company connects its platform to existing industrial control systems and uses operational data, audio and visual sensors, artificial intelligence, and machine learning to model facility performance in real time. Its platform determines operational adjustments and can autonomously modify set points, control logic, and coordination to improve production throughput and yield. Lumaril serves industrial facilities in manufacturing, chemicals, biologics, and oil and gas. The company applies AI-driven automation to existing industrial infrastructure without requiring replacement of established control systems. Its technology is designed to support continuous optimization of complex production environments.
  • Infisical — Infisical is the all-in-one identity security platform for developers, machines, and AI agents. Manage identities, secrets, certs, and access.
  • Serval — Serval is the AI-native ESM that automates employee requests, onboarding/offboarding, just-in-time access, and more.
Show all investments...

Bill Gates
Angel · Washington, District of Columbia, United States · 6 investments in Biotechnology startups

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Renewable Energy
  • Stage:Series C, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 95
  • Round size: Series A $12M–$105M; Series B $14M–$161M; Series C $14M–$135M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Koloma — Koloma is revolutionizing clean energy by harnessing naturally occurring hydrogen from deep within the Earth.
  • TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer.
  • Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Peter Thiel
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups, 17 in the past 12 months

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 286
  • Round size: Seed $1.2M–$10M; Series A $4M–$40M; Series B $13M–$105M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • BOB — Join Bob AI appears to be an AI technology platform that helps businesses automate workflows using AI agents and digital employees.
  • Etched — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
Show all investments...

Evan Cheng
Angel · Burlingame, California, United States · 6 investments in Biotechnology startups

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Australia

Investor stats

  • Total investments: 28
  • Round size: Seed $120k–$5.8M; Pre-Seed $150k–$10M; Series A $3M–$18M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jarsy — Start investing in Pre-IPO Companies with as little as $10. Jarsy is a pre-ipo marketplace platform that enables individuals worldwide to participate in top-tier private unicorns opportunities using stablecoins.
  • Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
  • Kite AI — An agnetic payment infrastructure empowering autonomous agents can operate with trust, governance, and native stablecoin settlement
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 6 investments in Biotechnology startups

Zach Weinberg is based out of New York, New York and is the founder & CEO of Curie.Bio. Zach previously worked at Flatiron Health as a co-founder, president & COO. Zach Weinberg attended the Wharton School of the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, Colombia

Investor stats

  • Total investments: 77
  • Round size: Seed $1.5M–$7.6M; Pre-Seed $1.5M–$2.3M; Series A $5M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Crosby — Crosby is an AI-first law firm that reviews contracts in under an hour. NDAs, MSAs, and DPAs handled with expert lawyers and AI working together.
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Show all investments...

Eric Kwan
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Show more...

Investment focus

  • Industry: Software, FinTech, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 58
  • Round size: Seed $1M–$9M; Pre-Seed $125k–$2M; Series A $3.4M–$21M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Treinta — Treinta powers 7 million SMBs across the US and Latin America with simple finance, inventory, and sales tools.
  • Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
  • Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot
Show all investments...

Tim Draper
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups, 19 in the past 12 months

Tim Draper is the Founding Partner of Draper Associates. He attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 333
  • Round size: Seed $350k–$5.9M; Series A $2.5M–$25M; Series B $3M–$50M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • CASIMIR —
  • illumicell AI — illumicell AI combines patented AI algorithms and proprietary microscopy technology to test 50x faster, 20x more effectively, empowering every healthcare provider at the point of care – not just fertility clinics – with accessible, scalable fertility diagnostics.
  • SignalRank — SignalRank owns a growing asset portfolio of top performing venture backed companies. It enters at Series B by helping early stage investors maintain their ownership in their best assets. The resulting portfolio is a top decile venture performer since inception in May 2023. SignalRank finances early stage investors’ pro-rata in qualifying Series B rounds through an automated process designed for speed, high-conviction selection, and partner-aligned economics. it can decide inside 24 hours and fund in less than a week. As a result SignalRank has 300+ seed partners who invite it to partner for pro-rata financing in their fastest growing companies. It sees a high percentage of all Series B term sheets prior to close. Capital is supplied from SignalRank’s balance sheet, with no capital calls or partner IC process delays. Check size correlates with capital available. SignalRank handles SPV setup and ongoing administration, with a target of moving from partner allocation request to funding in 5 business days. 20% of the profit on each investment goes directly to partners. SignalRank creates deal-by-deal SPVs; SignalRank does not charge management fees for this partner product. The portfolio can be seen at - https://signalrank.com/signalrank-index.html
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 6 investments in Biotechnology startups

Sake Bosch is based out of Amsterdam, North Holland, and is the founder and managing partner of Prime Ventures. Sake previously worked at SlimPay as a board member.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 34
  • Round size: Seed $1.3M–$7.2M; Series A $6.9M–$29M; Series B $7.1M–$101M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Alfa AI — Alfa AI sources, screens and shortlists candidates so your team only spends time on the people worth meeting.
  • YGO.AI — Richer, more accurate content for every hotel you sell, created automatically and ready for AI assistants.
  • TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
Show all investments...

Anne Wojcicki
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Anne E. Wojcicki is based out of Palo Alto, California and is the Co Founder & Member of the board of 23andMe. Anne previously worked at Passport Capital as a Healthcare Analyst. Anne E. Wojcicki attended the Yale University. Anne E. Wojcicki has been received the Top CEO award.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 65
  • Round size: Seed $1M–$12M; Series A $7M–$70M; Series B $19M–$63M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Nix, Inc. — Wearable single-use hydration sensor for athletes, soldiers, and laborers that measures hydration levels and informs when, what, and how much to drink.
  • The Invention Network — ScaleIP is an IP business intelligence platform that helps companies monetize IP.
  • Clair Health — Clair Health is building the first noninvasive wearable continuous hormone monitor. Track estrogen, progesterone, LH, FSH, and PdG in real-time. Join the Clair Health waitlist.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 6 investments in Biotechnology startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and Google News. Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy. Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences. Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 137
  • Round size: Seed $150k–$18M; Pre-Seed $500k–$6.6M; Series A $7.5M–$36M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Blockchain, Software, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, Canada

Investor stats

  • Total investments: 18
  • Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Freatic builds decentralized products around untapped information markets.
  • Niulinx — Politecnico di Milano spin-off building autonomous driving technology.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Daniel Curran
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups

Daniel Curran is the Founder and CEO at CustEx.com. He is retired from Angel investing due to a lack of exits.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Brazil

Investor stats

  • Total investments: 197
  • Round size: Seed $250k–$4.5M; Series A $3.4M–$16M; Series B $2.3M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
  • RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
  • GC Plus — Find Your Next Home Service Expert With Ease
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Maxim Basov
Angel · Dubai, Dubai, United Arab Emirates · 6 investments in Biotechnology startups

Maxim Basov

Show more...

Investment focus

  • Industry: Health Care, Apps, Legal
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Russian Federation, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $1.1M–$1.5M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Welltory — Your personal data analyzed and transformed into powerful insights that keep you on track for lifelong health
  • Elementaree — Elementaree makes food personal every day and delivers it on a subscription basis to the doorstep. We create personal food programs catered to particular needs and goals whether it’s about losing weight, creating tasty meals for your family or increasing your body muscles. Unique personalized programs at cost of a standard grocery check. We adoptour expertise in building value chains which allows us to customize at scale. A never-repeating variety of everyday menus and personalized add-ons catered to customers' specific needs.
  • Synchronization — Synchronization is an online course for music, philosophy, fashion and design, architecture, art, psychology, special projects, master classes, and cinema. They provide biology and a healthy lifestyle, film history, and film language.
Show all investments...

Cory Levy
Angel · San Francisco, California, United States · 6 investments in Biotechnology startups, 8 in the past 12 months

Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Canada, Peru

Investor stats

  • Total investments: 77
  • Round size: Seed $1.6M–$15M; Pre-Seed $200k–$3.3M; Series A $14M–$72M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Fun — Fun offers the highest converting rails to execute blockchain actions. Optimize your funding rails, reach new customers, and reduce costs.
  • Ghost — Ghost is a consumer hardware and software company building a private, local-first computing system for personal artificial intelligence.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 6 investments in Biotechnology startups

Kevin Moore has 15 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 109
  • Round size: Seed $300k–$4M; Pre-Seed $800k–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Trace — AI orchestration layer for modern teams
  • Augmend — Create documentation and an AI assistant from any video.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 6 investments in Biotechnology startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Swaap — We build & operate onchain trading systems. We are a group of scientists and technologists committed to build open systems.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Skedway connects software, AI, sensors, displays and automation into one intelligent operational layer for the physical workplace.
Show all investments...

Vishal Rao
Angel · Boston, Massachusetts, United States · 5 investments in Biotechnology startups

Advisory CTO and Angel Investor

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 84
  • Round size: Seed $500k–$8.8M; Pre-Seed $500k–$2.1M; Series A $3.8M–$25M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Aquaria — Aquaria provides solutions to secure access to clean water. The organization adapts its approaches based on the needs of these communities. It addresses water-related challenges through various methods.
  • Delphi — Delphi turns your expertise into an always-on presence, so you can grow your reach, serve your audience, and lead with clarity, without burning out.
  • Cambridge Terahertz — Cambridge Terahertz, a leader in terahertz (THz) imaging technology, offers an AI-powered Concealed Weapons Detection (CWD) solution to enhance workplace security. Our patent-pending system can see through clothing, luggage, plastic, paper, ceramics, and cardboard to detect concealed threats, including firearms, knives, and explosives.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 5 investments in Biotechnology startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 6
  • Round size: Seed $1.3M–$2.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Candan Karabagli
Angel · The Hague, Zuid-Holland, The Netherlands · 5 investments in Biotechnology startups

Candan Karabagli - Yönetim Kurulu Başkanı, CHAIRMAN @ GS Yuasa

Show more...

Investment focus

  • Industry: Biotechnology, Analytics, Biopharma
  • Stage:Seed, Angel, Series A
  • Geography: Turkey

Investor stats

  • Total investments: 6
  • Round size: Seed $280k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biolive — BIOLIVE was founded as a start-up company in Incubation Centre at Istanbul Technical University in 2016. The company transitioned to becoming a corporation with an investment from Vestel Ventures, a subsidiary of Zorlu Holding in 2017. Currently, the company produces bioplastic raw materials such as Bio-PE, Bio-PP, and Bio-ABS in scale-up andnext-gen materials such as plant-based leather and also offers sustainable solutions.
  • Vispera — Drive your retail execution to perfection with Vispera image recognition technologies and intelligent retail solutions.
  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

Brian Armstrong
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

Show more...

Investment focus

  • Industry: Biotechnology, Payments, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Brazil, Libya

Investor stats

  • Total investments: 19
  • Round size: Seed $2M–$25M; Series A $13M–$30M; Series B $45M–$130M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Brain Co. — AI platform and applications for the world's most important institutions
  • NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
  • Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
Show all investments...

Fred Ehrsam
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Fred Ehrsam is the Co-Founder of Paradigm.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Series A, Series C
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 54
  • Round size: Seed $1M–$12M; Series A $7M–$70M; Series C $65M–$300M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
  • Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
  • Arcadia Medicine — Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
Show all investments...

Alec Nielsen
Angel · Cambridge, Massachusetts, United States · 5 investments in Biotechnology startups

Alec Nielsen is the Founder & CEO at Asimov.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany

Investor stats

  • Total investments: 6
  • Round size: Seed $3M–$16M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
  • Lamin — Lamin provides an open data platform for biology, enabling tracked data management, streamlined collaboration, and learning at scale.
  • General Proximity — General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.
Show all investments...

Biotechnology Angel investor funding at a glance

Stats across 2.3k deals from 2.7k investors.

2.7k
investors
in Biotechnology startups
2.3k
deals
in Biotechnology startups
$5.7M
median round
in Biotechnology startups
14%
lead investors
lead at least one round
31%
Seed
most common funding stage

Access all 2708 angel investors in Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 2708 angel investors investing in Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists